Tyndall Capital Partners L P, 10% Owner at Onconova Therapeutics, Inc. (ONTX), sold 99,990 shares at $2.10 ($210K) on 2019-09-18, disclosed to the SEC on 2019-09-20.
Open-market sale of $210k ONTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 49,995 | $105K | 50.0% |
| 2 | $2.10 | 49,995 | $105K | 50.0% |
| Total | $2.10 avg | 99,990 | $210K | 100% |
| Filing → |
| ONTX | SELL | 2019-09-13 | $3K | — | Filing → |
| ONTX | SELL | 2019-09-11 | $1K | — | Filing → |
| ONTX | SELL | 2019-09-09 | $15K | — | Filing → |